168 OÊı·ÏÌÔÏÔÁ›·, 14, 2 (2002)‹‰Ë ÂÍÂÙ·Ûı¤ÓÙˆÓ ·ÙfïÓ. ŒÙÛÈ appleÚoÛ‹Ïı·ÓappleoÏÏ¿ ¿ÙoÌ· ¤Íˆ ·applefi Ùo ËÏÈÎÈ·Îfi fiÚÈo appleo˘ ›¯·-Ì ı¤ÛÂÈ, ¿ÙoÌ· ¯ˆÚ›˜ ηٷÁˆÁ‹ ·applefi ÙoÓ ÓoÌfi¤ÏÏ·˜ ‹ ¿ÙoÌ· appleo˘ ÂÓÒ ‹Ù·Ó ·applefi ÙoÓ ÓoÌfi ‰ÂÓÌappleoÚo‡Û·Ó Ó· Û˘ÌappleÂÚÈÏËÊıo‡Ó ÁÈ·Ù› appleϤoÓ Â›¯·-Ì ÛÙ·Ì·Ù‹ÛÂÈ ÙoÓ ¤ÏÂÁ¯o Û˘ÁÎÂÎÚÈÌ¤ÓˆÓ appleÂÚÈo-¯ÒÓ, ¤¯oÓÙ·˜ ηχ„ÂÈ ÙoÓ ·ÚÈıÌfi appleo˘ ›¯Â ·applefi ÙoÓۯ‰ȷÛÌfi appleÚoηıoÚÈÛÙ› ·Ó¿ appleÂÚÈo¯‹ Î·È ËÏÈ-Λ·. ∂apple›Û˘ ¿ÓıÚˆappleoÈ appleo˘ apple·Ú·ÎoÏo˘ıo‡ÓÙ·Ó ÁÈ·ÁÏ·‡ÎˆÌ· Î·È appleÚoÛ‹Ïı·Ó ÁÈ· ÌÈ· «‰Â‡ÙÂÚË» ÁÓÒ-ÌË. Δ¤Ïo˜, Û ÌÈ· ¤Í·ÚÛË ˙‹Ïo˘, ‰È¢ı˘ÓÙ¤˜ Û¯o-Ï›ˆÓ ‹ ˘appleËÚÂÛÈÒÓ ¤ÛÙÂÏÓ·Ó fiÏo˘˜ ·ÓÂÍ·ÈÚ¤Ùˆ˜Ùo˘˜ ÂÚÁ·˙o̤Óo˘˜ Ùo˘˜, ·ÓÂÍ·ÚÙ‹Ùo˘ ËÏÈΛ·˜ ηÈηٷÁˆÁ‹˜, ÁÈ· «˘appleo¯ÚˆÙÈÎfi» ηْ ·˘Ùo‡˜ appleÚo-ÏËappleÙÈÎfi ¤ÏÂÁ¯o. º˘ÛÈο Ù· ¿ÙoÌ· appleo˘ ‰ÂÓ appleÏË-Úo‡Û·Ó ÙȘ appleÚo¸appleoı¤ÛÂȘ ‰ÂÓ Û˘ÌappleÂÚÈÏ‹ÊıËηÓÛÙoÓ ¤ÏÂÁ¯o.¿ÓÙˆ˜, Ë appleÂÚÈo¯‹ Ù˘ ¤ÏÏ·˜ ÌÂÏÂÙ¿Ù·È ÁÈ·appleÚÒÙË ÊoÚ¿ Î·È Ì¿ÏÈÛÙ· ·˘Ùfi Á›ÓÂÙ·È Ì ¤Ó·ÓÙÚfiappleo appleo˘ ηχappleÙÂÈ Ùo Û‡ÓoÏo ÙˆÓ ËÏÈÎÈ·ÎÒÓ o-Ì¿‰ˆÓ, appleo˘ ı· ÌappleoÚo‡Û·Ó Ó· apple·Úo˘ÛÈ¿˙o˘Ó ∞ ‹appleÚÒÈÌ· ÛËÌ›· ·˘Ùo‡.π‰È·›ÙÂÚ· Ë Î·Ù·ÁÚ·Ê‹ Ùo˘ ÂappleÈappleoÏ·ÛÌo‡ Ùo˘∞ ÛÙȘ ÓÂfiÙÂÚ˜ ËÏÈ˘ ¤¯ÂÈ Í¯ˆÚÈÛÙfi ÂӉȷ-ʤÚoÓ, ηıÒ˜ Â›Ó·È ‰˘Ó·ÙfiÓ Ù· ›‰È· ¿ÙoÌ· Ó· Âapple·-ÓÂÍÂÙ·ÛÙo‡Ó ÛÙo ̤ÏÏoÓ Î·È Ó· ÂappleȂ‚·Èˆı› ‹ Ó··appleoÚÚÈÊı›, ·Ó¿ÏoÁ·, Ë ˘applefiıÂÛË Ù˘ ‡apple·Ú͢appleÚÒÈÌˆÓ ÎÏÈÓÈÎÒÓ ÛËÌ›ˆÓ ÛÙo ∞.Δ· ÛÙoȯ›· Ù˘ ÂÚÁ·Û›·˜ ·˘Ù‹˜ ¤Ú¯oÓÙ·È Ó·appleÚoÛÙÂıo‡Ó ÛÙËÓ oÌ¿‰· ÂÚÁ·ÛÈÒÓ 3,9-18 , fiappleo˘ Â-Ú¢ӋıËΠ¤ˆ˜ Û‹ÌÂÚ· o ÂappleÈappleoÏ·ÛÌfi˜ Ùo˘ ∞ÛÙoÓ ÂÏÏ·‰ÈÎfi ¯ÒÚo Î·È ‚Ú¤ıËΠӷ Î˘Ì·›ÓÂÙ·È ÛÂappleoÛoÛÙ¿ ·applefi 6,5% ¤ˆ˜ 25%. ÚfiÎÂÈÙ·È ‰Â ÁÈ· ÌÈ··applefi ÙȘ Ï›Á˜ ÌÂϤÙ˜ appleo˘ ·Ó·Ê¤ÚoÓÙ·È ÛÙoÓ ÁÂÓÈ-Îfi appleÏËı˘ÛÌfi Î·È Û ‰È·ÛÙڈ̷و̤Óo ‰Â›ÁÌ··˘Ùo‡.˘ÌappleÂÚ¿ÛÌ·Ù·ÙËÓ ÌÂϤÙË ·˘Ù‹ ηٷÁÚ¿ÊËΠo ÂappleÈappleoÏ·-ÛÌfi˜ Ùo˘ ∞ Û ·ÓÙÈappleÚoÛˆapple¢ÙÈÎfi ‰Â›ÁÌ· Ùo˘appleÏËı˘ÛÌo‡ Ùo˘ ÓoÌo‡ ¤ÏÏ·˜, Ùo oappleo›o ·appleoÙÂÏo‡-ÓÙ·Ó ·applefi 700 ÂÓ‹ÏÈΘ ·applefi 45 ÂÙÒÓ Î·È ¿Óˆ.ŸÏ· Ù· ¿ÙoÌ· appleo˘ ÂÍÂÙ¿ÛÙËÎ·Ó Â›¯·Ó ηٷ-ÁˆÁ‹ ·applefi ÙoÓ ÓoÌfi ¤ÏÏ·˜ Î·È Î·Ó¤Ó·˜ ·applefi ¿ÏÏËappleÂÚÈo¯‹ Ù˘ ∂ÏÏ¿‰·˜. ∏ ÌÂϤÙË ‰ËÏ·‰‹ ·ÊoÚ¿·ÌÈÁÒ˜ ÙoÓ appleÏËı˘ÛÌfi Ùo˘ ÓoÌo‡ ¤ÏÏ·˜.ªÂ ‚¿ÛË Ù· ÎÏÈÓÈο ¯·Ú·ÎÙËÚÈÛÙÈο Ùo˘ ‰Â›Á-Ì·Ùo˜ appleÏËı˘ÛÌo‡ appleo˘ ÂÍÂÙ¿ÛÙËÎÂ, ÎÏÈÓÈο ·ÓÈ-¯Ó‡ÛÈÌo ∞ ‚Ú¤ıËÎÂ Û˘ÓoÏÈο Û appleoÛoÛÙfi 10%(70 ·ÛıÂÓ›˜ ·applefi 700 ÂÍÂÙ·Ûı¤ÓÙ˜). Δo appleoÛoÛÙfi·˘Ùfi ·Ó‚·›ÓÂÈ ‰Ú·Ì·ÙÈο Û ۯ¤ÛË Ì ÙËÓ ËÏÈΛ·.ŒÙÛÈ Â›Ó·È 0% ÛÙËÓ ‰ÂηÂÙ›· 45-54 (0 ·ÛıÂÓ›˜ ÛÂ250 ÂÍÂÙ·Ûı¤ÓÙ˜), 2% ÛÙËÓ ‰ÂηÂÙ›· 55-64 (4·ÛıÂÓ›˜ Û 200 ÂÍÂÙ·Ûı¤ÓÙ˜), 21,33% ÛÙËÓ ‰Â-ηÂÙ›· 65-74 (32 ·ÛıÂÓ›˜ ·applefi 150 ÂÍÂÙ·Ûı¤ÓÙ˜)Î·È 34% ÛÙȘ ËÏÈ˘ ·applefi 75 Î·È ¿Óˆ (34 ·ÛıÂÓ›˜·applefi 100 ÂÍÂÙ·Ûı¤ÓÙ˜).ËÌ·ÓÙÈÎfi Â›Ó·È Ó· ·Ó·Ê¤Úo˘Ì fiÙÈ ÛÙ·ÙÈÛÙÈ-ο ÛËÌ·ÓÙÈ΋ ‰È·ÊoÚ¿ ‰ÂÓ ‰È·appleÈÛÙÒıËΠˆ˜ appleÚo˜ÙoÓ ÂappleÈappleoÏ·ÛÌfi Ùo˘ ∞ ÌÂٷ͇ ÙˆÓ ÙÚÈÒÓ Âapple·Ú-¯ÈÒÓ Ùo˘ ÓoÌo‡ ¤ÏÏ·˜ (∞Ï̈apple›·˜, °È·ÓÓÈÙÛÒÓÎ·È Œ‰ÂÛÛ·˜).∏ apple·Úo‡Û· ÌÂϤÙË ·appleoÙÂÏ› ¤Ó· ÂappleÈappleϤoÓÛÙoȯ›o ÛÙËÓ ÁÂÓÈÎfiÙÂÚË appleÚoÛapple¿ıÂÈ· ÁÈ· ·ÎÚÈ‚‹Î·È ÏÂappleÙoÌÂÚ‹ ηٷÁÚ·Ê‹ Ùo˘ ÌÂÁ¤ıo˘˜ Âapple›appleÙˆ-Û˘ Ùo˘ ∞ ÛÙËÓ ¯ÒÚ· Ì·˜ Î·È ÛÙoÓ ÎfiÛÌo ÁÂÓÈ-ÎfiÙÂÚ·.Δ· Û˘ÌappleÂÚ¿ÛÌ·Ù· ÛÙ· oappleo›· ηٷϋͷÌ ›-Ó·È Ù· ÂÍ‹˜:• Δo ∞, ÌÈ· ÂÎÊ˘ÏÈÛÙÈ΋ ÓfiÛo˜ Û˘¯Ó‹ ÛÙËÓ∂ÏÏ¿‰·, Û˘Ó·ÓÙ¿Ù·È ÛÙo˘˜ ηÙo›Îo˘˜ Ùo˘ ÓoÌo‡¤ÏÏ·˜ ¿Óˆ ÙˆÓ 45 ÂÙÒÓ, Û appleoÛoÛÙfi 10%. ·-Úo˘ÛÈ¿˙ÂÈ ‰Â Ï›·Ó ÛËÌ·ÓÙÈ΋ ıÂÙÈ΋ ÛÙ·ÙÈÛÙÈ΋ Û˘-Û¯¤ÙÈÛË Ì ÙËÓ ËÏÈΛ· ηıÒ˜ ·˘Í¿ÓÂÙ·È ‰Ú·Ì·ÙÈοÛÙËÓ ÙÚ›ÙË ËÏÈΛ· Î·È ÛÙo˘˜ ˘appleÂÚ‹ÏÈΘ. Δo ∞ ÂÌ-Ê·Ó›˙ÂÙ·È Ùo ›‰Èo Û˘¯Ó¿ ÙfiÛo ÛÙo˘˜ ¿Ó‰Ú˜ fiÛoÎ·È ÛÙȘ Á˘Ó·›Î˜.• ËÌ·ÓÙÈÎfi ÚfiÏo ÛÙËÓ ·ÛÊ·Ï‹ ‰È¿ÁÓˆÛË Ùo˘∞ apple·›˙ÂÈ Ë Ì˘‰Ú›·ÛË, ·Êo‡ appleoÏÏ¿ ¿ÙoÌ· (ÛÙËÓapple·Úo‡Û· ÂÚÁ·Û›· 18 ·ÛıÂÓ›˜, appleoÛoÛÙfi 25,71%ÙˆÓ ·appleoÊoÏȉˆÙÈÎÒÓ ·ÙfïÓ) ¤¯o˘Ó ÛÙoȯ›· ·appleo-ÊoÏ›‰ˆÛ˘ appleÚoÛı›o˘ appleÂÚÈʷΛo˘ (Û˘¯Ó¿ ‰‡ÛÎoÏ·oÚ·Ù¿ ¯ˆÚ›˜ Ì˘‰Ú›·ÛË), ¯ˆÚ›˜ Ó· apple·Úo˘ÛÈ¿˙o˘Ó·apple·Ú·›ÙËÙ· ·appleoÊoÏ›‰ˆÛË ÎoÚÈÎo‡ ¯Â›Ïo˘˜.• Δo ∞ Û˘Û¯ÂÙ›˙ÂÙ·È ıÂÙÈο Ì ·˘ÍË̤ÓË ÂÓ-‰oÊı¿ÏÌÈ· apple›ÂÛË (∂O), ›Ù appleÚfiÎÂÈÙ·È ÁÈ· ˘appleÂÚ-ÙoÓ›·, ›Ù ÁÈ· ÁÏ·‡ÎˆÌ·. ŒÙÛÈ Ë Ì¤ÛË ∂O ›ӷÈ15,37 mmHg (SD:3,52) ÛÙo˘˜ 630 ÌË ·appleoÊoÏȉˆ-ÙÈÎo‡˜ ÂÍÂÙ·Ûı¤ÓÙ˜ ¤Ó·ÓÙÈ 20,04 mmHg (SD:6,33) ÛÙo˘˜ ·appleoÊoÏȉˆÙÈÎo‡˜. ∂appleÈappleϤoÓ, ·applefi Ùo˘˜ÁÏ·˘ÎˆÌ·ÙÈÎo‡˜ appleo˘ ‰È·ÁÓÒÛÙËÎ·Ó ÛÙo ÂÍÂÙ·˙fi-ÌÂÓo ‰Â›ÁÌ· oÈ 12 (50%) ›¯·Ó ·appleoÊoÏȉˆÙÈÎfiÁÏ·‡ÎˆÌ· ÂÓÒ oÈ 9 (37,5%) ¯ÚfiÓÈÔ ÁÏ·‡ÎˆÌ· ·-Óoȯً˜ ÁˆÓ›·˜ Î·È oÈ 3 (12,5%) ÁÏ·‡ÎˆÌ· Ê˘-ÛÈoÏoÁÈ΋˜ apple›ÂÛ˘.• ∂ÙÂÚfiappleÏ¢ÚË ·appleoÊoÏ›‰ˆÛË ÂÌÊ·Ó›˙ÂÙ·È ÛÂ22 ¿ÙoÌ· (31,42% ÙˆÓ ·ÙfiÌˆÓ Ì ·appleoÊoÏ›‰ˆÛË),ÂÓÒ ·ÌÊoÙÂÚfiappleÏ¢ÚË Û 48 ¿ÙoÌ· (68,58% ÙˆÓ·ÙfiÌˆÓ Ì ·appleoÊoÏ›‰ˆÛË), ÛÙoȯ›o appleo˘ Û˘ÓËÁo-Ú› Ì ÙËÓ ¿appleo„Ë fiÙÈ Ë ÂÙÂÚfiappleÏ¢ÚË ·appleoÊoÏ›‰ˆÛË
OÊı·ÏÌÔÏÔÁ›·, 14, 2 (2002) 169appleÚoo‰Â˘ÙÈο ÌÂÙ·ÙÚ¤appleÂÙ·È Û ·ÌÊoÙÂÚfiappleÏ¢ÚË.• ∏ Û˘Ó‡apple·ÚÍË ·appleoÊoÏ›‰ˆÛ˘ Î·È ˘appleÂÚÙo-Ó›·˜ Â›Ó·È Ùo ›‰Èo Û˘¯Ó‹ Û ¿Ó‰Ú˜ Î·È Á˘Ó·›Î˜.• ∏ ÁˆÓ›· Ùo˘ appleÚoÛı›o˘ ı·Ï¿Ìo˘ ‚Ú¤ıËÎÂ(¢ڤˆ˜) ·Óoȯً Î·È Ì ¿ÊıoÓË ¯ÚˆÛÙÈ΋ (¯Úˆ-ÛÙÈ΋ ππ Î·È πππ ‚·ıÌo‡ ΢ڛˆ˜) Û fiÏo˘˜ Ùo˘˜oÊı·ÏÌo‡˜ Ì ·appleoÊoÏ›‰ˆÛË.• ∏ Îo›Ï·ÓÛË Ùo˘ oappleÙÈÎo‡ Ó‡Úo˘ ‹Ù·Ó ÛÙ·ÙÈ-ÛÙÈο ÛËÌ·ÓÙÈο ·˘ÍË̤ÓË ÛÙ· ¿ÙoÌ· Ì ∞ (̤-ÛË ÙÈÌ‹: 0,36) Û ۯ¤ÛË Ì ٷ ¿ÙoÌ· ¯ˆÚ›˜ ∞ (̤-ÛË ÙÈÌ‹: 0,26). Δo ‡ÚËÌ· Û˘ÓËÁoÚ› Ì ٷ ̤¯ÚÈÛ‹ÌÂÚ· ‰Â‰o̤ӷ, Û¯ÂÙÈο Ì ÙȘ ·applefiÙo̘ ·˘ÍË-ÙÈΤ˜ ‰È·Î˘Ì¿ÓÛÂȘ (peak) Ù˘ ∂O ÙˆÓ ·appleo-ÊoÏȉˆÙÈÎÒÓ oÊı·ÏÌÒÓ Î·È ÙȘ Âapple·ÎfiÏo˘ı˜ ‰Ú·-Ì·ÙÈΤ˜ Û˘Ó¤appleÂȘ ÁÈ· Ùo oappleÙÈÎfi Ó‡Úo Î·È ÙËÓÏÂÈÙo˘ÚÁ›· Ù˘ fiÚ·Û˘.∞˘Ùfi Î·È ÌfiÓo Ùo ÁÂÁoÓfi˜ ·appleo‰ÂÈÎÓ‡ÂÈ applefiÛoÛËÌ·ÓÙÈ΋ Â›Ó·È Ë ¤ÁηÈÚË ‰È¿ÁÓˆÛË Ùo˘ ∞ ηÈÙ˘ appleÈı·Ó‹˜ ˘appleÂÚÙoÓ›·˜ ‹ ÁÏ·˘ÎÒÌ·Ùo˜, appleÚ¿ÁÌ·appleo˘ ÌappleoÚ› Ó· ÂappleÈÙ¢¯ı› ÌfiÓo Ì appleÚoÏËappleÙÈÎfi ¤-ÏÂÁ¯o, ·Êo‡ Ùo ∞ fiÛo Î·È Ë ˘appleÂÚÙoÓ›· Â›Ó·È ·Û˘-Ìappleو̷ÙÈο.Δ¤Ïo˜, ·Í›˙ÂÈ Ó· ÛËÌÂȈı› Ë ÛËÌ·Û›· Ùo˘appleÚoÏËappleÙÈÎo‡ ÂϤÁ¯o˘ appleo˘ ‰È·Ê·›ÓÂÙ·È Ì¤Û· ·applefi·˘Ù‹Ó ÙËÓ ÌÂϤÙË, ÌfiÓo Î·È ÌfiÓo ·Ó ·Ó·ÊÂÚı› ÙoÁÂÁoÓfi˜ fiÙÈ ·applefi Ùo˘˜ 700 Û˘ÓoÏÈο «˘ÁÈ›˜» ÂÍÂ-Ù·Ûı¤ÓÙ˜, Ìapple‹Î·Ó Û ıÂÚ·apple›· Î·È apple·Ú·ÎoÏo‡-ıËÛË ‹ apple·Ú·apple¤ÌÊıËÎ·Ó ÁÈ· ¤ÏÂÁ¯o Î·È Ú‡ıÌÈÛËÛ ÂȉÈÎfi oÊı·ÏÌoÏoÁÈÎfi È·ÙÚ›o ‹ Û ¿ÏϘ È·-ÙÚÈΤ˜ ÂȉÈÎfiÙËÙ˜, 160 ¿ÙoÌ· (appleoÛoÛÙfi 22,86%Ùo˘ Û˘ÓfiÏo˘ Ùo˘ ‰Â›ÁÌ·Ùo˜).μÈ‚ÏÈoÁÚ·Ê›·1. ∫ÒÓÛÙ·˜ ∞°, Marshall GE, ∫oÏÈ¿Îo˜ °, Lee WR, ΔÚ·-η٤ÏÏ˘ ∞. ∏ ʇÛË Ùo˘ ·appleoÊoÏȉˆÙÈÎo‡ ˘ÏÈÎo‡.OÊı·ÏÌoÏoÁ›· 5: 347-360, 1993.2. ∫ÒÓÛÙ·˜ ∞°, ¢ËÌËÙÚ·Îo‡ÏÈ·˜ ¡, ∫·Ú‰·Ûfiappleo˘Ïo˜ ∞.∫ÏÈÓÈο ¯·Ú·ÎÙËÚÈÛÙÈο Ùo˘ ·appleoÊoÏȉˆÙÈÎo‡ ÁÏ·˘-ÎÒÌ·Ùo˜. ∂ÈÛËÁ‹ÛÂȘ 27o˘ ·ÓÂÏÏ‹ÓÈo˘ OÊı·ÏÌo-ÏoÁÈÎo‡ ˘Ó‰ڛo˘ 90-97, 1994.3. ª˘Ïfiappleo˘Ïo˜ ¡. ∂appleȉËÌÈoÏoÁÈ΋ ÌÂϤÙË „¢‰o·appleoÊoÏÈ-‰ˆÙÈÎo‡ ÁÏ·˘ÎÒÌ·Ùo˜ ÛÙË μfiÚÂÈo ∂ÏÏ¿‰·. OÊı·Ï-ÌoÏoÁÈο ÃÚoÓÈο 29: 181-187, 1992.4. ∫ÒÓÛÙ·˜ ∞°. ∫ÏÈÓÈ΋ ÛËÌÂÈoÏoÁ›· Ùo˘ ·appleoÊoÏȉˆ-ÙÈÎo‡ Û˘Ó‰ÚfiÌo˘. OÊı·ÏÌoÏoÁ›· 7: 126-137, 1995.5. Schlotzer-Schrehardt U, Koca MR, Naumann GOH, VolkholzH. Pseudoexfoliation syndrom. Ocular manifestationof a systemic disorder? Arch Ophthalmol 110:1752-1756, 1992.6. Streeten BW, Li ZY, Wallace RN, Eagle RC, KeshgegianAA. Pseudoexfoliative fibrillopathy in visceral organsof a patient with pseudoexfoliation syndrom. ArchOphthalmol 110: 1757-1762, 1992.7. Naumann OH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliationsyndrome for the comprehensive ophthalmologist.Intraocular and systemic manifestations.Ophthalmology 105: 951-968, 1998.8. McCarty CA, Taylor HR. Pseudoexfoliation syndrome inAustralian adults. American Journal Ophthalmology129: 629-633, 2000.9. Trantas M. Lesions Seniles de la capsule anterieure ducristallin et du bord pupillaire. Archives d’ Ophthalmologie46: 482-491, 1929.10. Ioannides T, Katsourakis N, Velissaropoulos P. Glaucomacapsulare. Ophthalmologica 142: 160-189: 1961.11. ΔÚ·Á¿Î˘ ª, oÏÏ¿Ï˘ , °·ÚÙ·Á¿Ó˘ . 梉o·appleo-ÊoÏȉÒÛÂȘ. ¢ÂÏÙ›o Ù˘ ∂ÏÏËÓÈ΋˜ OÊı·ÏÌoÏoÁÈ΋˜ÂÙ·ÈÚ›·˜ 46: 161-169, 1978.12. ΔÚÈ·ÓٷʇÏÏo˘ °. 梉o·appleoÊoÏ›‰ˆÛË Ùo˘ appleÂÚÈÊ·-Λo˘. ¢È·ÙÚÈ‚‹ Âapple› ‰È‰·ÎÙoÚ›·, £ÂÛÛ·ÏoÓ›ÎË, 1980.13. Stefaniotou M, Petroutsos G, Psilas K. The frequency ofpseudoexfoliation in a region of Greece (Epirus). A-cta Ophthalmol 68: 307-309, 1990.14. ΔÛo‡ÙÛo˜ ∫, ¢ËÌËÙÚÈ¿‰Ë˜ μ, °·‚ÚÈ‹Ï §. ∏ Û˘¯ÓfiÙËÙ·Ù˘ „¢‰o·appleoÊoÏȉÒÛˆ˜ ÛÙoÓ ∂ÏÏËÓÈÎfi appleÏËı˘ÛÌfi.OÊı·ÏÌoÏoÁÈο ¯ÚoÓÈο 29: 303-310, 1992.15. Konstas AGP, Dimitracoulias N, Kourtzidou O, Filidis K,Bufidis T, Benos A. Frequency of exfoliation syndromein Greec cataract patients. Acta Ophthalmol 74: 478-482, 1996.16. ÙÂÊ·ÓÈÒÙo˘ ª. ∏ Û˘¯ÓfiÙËÙ· Ù˘ „¢‰o·appleoÊoÏ›‰ˆÛ˘ÛÙËÓ ◊appleÂÈÚo. ¢È‰·ÎÙoÚÈ΋ ‰È·ÙÚÈ‚‹, πˆ¿ÓÓÈÓ· 1989.17. ∫o˙oÌapplefiÏ˘ μ. ∏ „¢‰o·appleoÊoÏ›‰ˆÛË ÛÙËÓ ∫Ú‹ÙË.(ÂÚ›ÏË„Ë ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹˜) OÊı·ÏÌoÏoÁ›·9: 76-88, 1997.18. ªappleo˘Ê›‰Ë˜ £. O ÂappleÈappleoÏ·ÛÌfi˜ Ùo˘ Û˘Ó‰ÚfiÌo˘ ·appleoÊo-Ï›‰ˆÛ˘ ÛÂ Ù˘¯·›o ‰Â›ÁÌ· appleÏËı˘ÛÌo‡ Ù˘ ¢ڇÙÂÚ˘appleÂÚÈo¯‹˜ £ÂÛÛ·Ïoӛ΢. ¢È‰·ÎÙoÚÈ΋ ‰È·ÙÚÈ‚‹,£ÂÛÛ·ÏoÓ›ÎË 1998.19. Konstas AGP, Lay JL, Marshall GE, Lee WR. Prevalence,diagnostic features, and response to trabeculectomyin exfoliation glaucoma. Ophthalmology 100: 619-627, 1993.20. Konstas AGP. Morphological and clinical studies on theexfoliation syndrome and open angle glaucoma. Ph DThesis Glascow 1-364, 1993.21. Gifford H. A clinical and pathological study of exfoliationof the lens capsule. Trans Am Ophthalmol Soc55: 189-216, 1957.22. Tarkkanen AH. Pseudoexfoliation of the lens capsule.Acta Ophthalmol Suppl 71: 9-98, 1962.23. Bertelsen TI. Fibrillopathia epitheliocapsularis. The socalledsenile exfoliation or pseudoexfoliation of theanterior lens capsule. Acta Ophthalmol 44: 737-750,1966.24. Hansen E, Sellevold OJ. Pseudoexfoliation of the lenscapsule. II. Development of the exfoliation syndrome.
- Page 5 and 6: ¯fiÏÈÔO Û‚·ÛÙfi˜ K·ı
- Page 7 and 8: OphthalmologiaContentsVolume 14 - N
- Page 9 and 10: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 11 and 12: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 13 and 14: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 15 and 16: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 17 and 18: AÓ·ÛÎfiappleËÛË∂appleÈÌ
- Page 19 and 20: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 21 and 22: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 23 and 24: ∫ÏÈÓÈΤ˜ Î·È ÂÚÁ·Û
- Page 25 and 26: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 27 and 28: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 29: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 33 and 34: ‡ÁÎÚÈÛË Ù˘ 24ˆÚ˘
- Page 35 and 36: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 37 and 38: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 39 and 40: ∏ ¯Ú‹ÛË Ù˘ ·ÏÏ·ÓÙ
- Page 41 and 42: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 43 and 44: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 45 and 46: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 47 and 48: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 49 and 50: OÊı·ÏÌÈο ÙÚ·‡Ì·Ù·
- Page 51 and 52: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 53 and 54: OappleÙÈ΋ o͇ÙËÙ·, ‰
- Page 55 and 56: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 57 and 58: ∂ӉȷʤÚÔÓÙ· appleÂ
- Page 60 and 61: 198 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 62 and 63: 200 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 64 and 65: 202 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 66 and 67: 204 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 68 and 69: ‡ÌÌÂÈÎÙ·∂appleÈ̤ÏÂ
- Page 70 and 71: 208 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 72 and 73: O ÔÊı·ÏÌfi˜ οÙÔappleÙ
- Page 74 and 75: 212 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 76 and 77: 214 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 78 and 79: ·ıÔÁ¤ÓÂÈ· Ù˘ ˘appleÂ
- Page 80 and 81:
218 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 82 and 83:
220 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 84 and 85:
222 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 86 and 87:
224 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 88 and 89:
226 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 90 and 91:
228 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 92 and 93:
230 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 94 and 95:
232 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 96 and 97:
234 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 98 and 99:
236 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 100 and 101:
238 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 102 and 103:
240 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 104 and 105:
242 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 106 and 107:
244 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 108 and 109:
246 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 110 and 111:
248 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 112 and 113:
ÂÚÈÏ‹„ÂȘ ·applefi ͤ
- Page 114 and 115:
252 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 116 and 117:
254 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 118 and 119:
256 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 120 and 121:
BÈ‚ÏÈÔÎÚÈÛ›·¡ÈÎfiÏ
- Page 122 and 123:
260 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 124:
Eȉ‹ÛÂȘ∂appleÈ̤ÏÂ